Stenabolic (SR9009) for Circadian Rhythm Studies: A Technical Review of Rev-ErbA Ligands

Stenabolic (SR9009) is not merely a metabolic enhancer but a precision molecular tool for re-syncing the core circadian clock via Rev-ErbA agonism. In the rigorous environment of molecular biology, the application of Stenabolic (SR9009) for circadian rhythm studies requires a profound understanding of its binding affinity, specifically its IC50 values of 670 to 710 nM for Rev-ErbA alpha. You likely recognize that inconsistent chemical purity and a lack of detailed documentation often compromise experimental integrity. These variables introduce noise into sensitive in-vitro models, making it difficult to isolate the specific effects of Rev-ErbA activation on metabolic homeostasis.

This technical review provides a comprehensive scientific analysis of the mechanisms underlying SR9009, focusing on its role in modulating gene expression within laboratory models. We’ll establish a precise protocol for in-vitro circadian rhythm manipulation while addressing the critical need for stable, third-party tested ligands in European research settings. By examining the molecular pathways and current stability data, this documentation ensures your research designs are built on a foundation of verifiable, high-purity metrics. We will analyze the transition from Rev-ErbA agonism to systemic metabolic shifts, providing the clarity necessary for sophisticated professional inquiry.

Key Takeaways

  • Understand the molecular classification of SR9009 as a synthetic ligand targeting Rev-ErbA alpha and beta receptors.
  • Establish a protocol for applying Stenabolic (SR9009) for circadian rhythm studies through the suppression of BMAL1 and CLOCK gene transcription.
  • Evaluate the metabolic implications of Rev-ErbA agonism, focusing on lipid metabolism and glucose oxidation within in-vitro models.
  • Follow validated laboratory procedures for the reconstitution and solubility of ligands in DMSO or Ethanol to ensure analytical consistency.
  • It’s vital to source high-purity chemicals that undergo independent third-party testing to prevent off-target effects in complex research designs.

Understanding Stenabolic (SR9009) as a Synthetic Rev-ErbA Agonist

Ethyl 3-[[[4-chlorophenyl)methyl][(5-nitro-2-thienyl)methyl]amino]methyl]-1-pyrrolidinecarboxylate, commercially identified as SR9009 (Stenabolic), represents a critical advancement in the study of nuclear receptor pharmacology. It’s classified as a synthetic ligand for the nuclear receptors Rev-ErbAα and Rev-ErbAβ, which function as constitutive transcriptional repressors. Unlike many compounds utilized in longevity research that rely on peptide-based signaling or hormonal modulation, SR9009 operates through a direct interaction with the core molecular clock machinery. It’s not a Selective Androgen Receptor Modulator (SARM), a common misconception in non-professional literature. Instead, its primary laboratory utility lies in metabolic and chronobiological research, where it serves as a high-affinity tool for investigating the synchronization of biological processes.

The application of Stenabolic (SR9009) for circadian rhythm studies allows for the precise manipulation of gene transcription within the negative feedback loops that govern cellular timing. By acting as an agonist, SR9009 enhances the repressive activity of Rev-ErbA, leading to the downregulation of downstream targets involved in glucose and lipid metabolism. This specific mechanism of action provides a verifiable metric for researchers seeking to isolate the effects of circadian oscillation on systemic homeostasis.

The Discovery and Evolution of Rev-ErbA Ligands

The identification of SR9009 originated in the laboratory of Professor Thomas Burris at the Scripps Research Institute. Initial investigations focused on the potential of Rev-ErbA ligands to address metabolic syndromes, specifically targeting cholesterol and fatty acid synthesis. However, the scope of research shifted as the profound influence of Rev-ErbA on core circadian clock regulation became evident. SR9009 emerged as a primary tool for Rev-ErbA agonism studies because it demonstrates superior potency compared to earlier ligands like GSK4112. It’s now the standard for probing the link between the molecular clock and physiological endurance, providing a reliable baseline for chronobiological assays.

Chemical Structure and Binding Affinity

The molecular structure of SR9009 is engineered to facilitate high-affinity binding to the ligand-binding domain (LBD) of Rev-ErbA receptors. This binding triggers the recruitment of the NCoR-HDAC3 corepressor complex, which subsequently inhibits the transcription of clock-controlled genes. Technical analysis confirms the following binding metrics:

  • Rev-ErbAα IC50: Approximately 670 to 710 nM.
  • Rev-ErbAβ IC50: Approximately 800 nM.
  • Selectivity: High specificity for Rev-Erb receptors over other nuclear receptors like PPARs or LXRs.

Analytical consistency is paramount in these studies. Chemical purity is a non-negotiable requirement for ensuring binding specificity. Even minor contaminants can lead to off-target effects, compromising the data collected from sensitive cell line models. Professional researchers rely on third-party validated chemicals to maintain the integrity of their experimental designs, as the precision of the IC50 values directly dictates the accuracy of the resulting metabolic profiles.

The Molecular Clock: How SR9009 Modulates Circadian Oscillations

The mammalian circadian clock operates via a cell-autonomous negative feedback loop. The transcription factors BMAL1 and CLOCK form a heterodimer that binds to E-box elements, driving the expression of Period (PER) and Cryptochrome (CRY) proteins. Once these proteins accumulate in the cytoplasm, they translocate back into the nucleus to inhibit their own transcription. Utilizing Stenabolic (SR9009) for circadian rhythm studies allows researchers to target an auxiliary loop that intersects with this core mechanism, providing direct control over the amplitude and phase of cellular oscillations.

Administering SR9009 alters the transcription profile of clock-controlled genes by locking the Rev-ErbA receptor into an active, repressing conformation. This intervention induces a profound down-regulation of BMAL1 expression. In “clock-in-a-dish” research models, this targeted suppression allows for the precise mapping of temporal gene networks without the confounding variables present in living organisms.

Regulation of the BMAL1/CLOCK Feedback Loop

The auxiliary feedback loop depends on competitive binding at the ROR response element (RORE) promoter site. Retinoid-related Orphan Receptors (RORs) activate BMAL1 transcription, while Rev-ErbA alpha and beta suppress it. When SR9009 binds to the ligand-binding domain of Rev-ErbA, it accelerates the recruitment of corepressors, tipping the balance toward potent transcriptional repression. In synchronized cell cultures, this molecular shift causes predictable phase-shifting effects. The timing of ligand introduction dictates whether the circadian oscillation experiences a phase advance or a phase delay, demonstrating the compound’s utility as a temporal dial.

Tissue-Specific Circadian Responses

Peripheral clocks exhibit distinct, tissue-specific responses to Rev-ErbA activation. In hepatic tissue, SR9009 directly alters the expression of genes regulating bile acid synthesis and gluconeogenesis. Conversely, in skeletal muscle tissue, the compound influences mitochondrial biogenesis and lipid oxidation pathways. These differences highlight the complex nature of peripheral clock synchronization, where the same molecular ligand yields divergent metabolic outputs based on the cellular environment. Furthermore, adipose tissue displays a heavy circadian dependency; SR9009 administration modulates thermogenic gene expression, altering brown adipose tissue activity in a time-of-day-dependent manner.

For laboratories executing these intricate in-vitro protocols, maintaining baseline accuracy requires verified reference materials. Researchers can acquire high-purity ligands for their assays by exploring the advanced metabolic stack components available through certified European distribution channels.

Metabolic Homeostasis and Circadian Disruption Models

Circadian disruption is a primary driver of metabolic dysfunction, often manifesting as impaired glucose tolerance and dyslipidemia in laboratory models. Research designs utilizing Stenabolic (SR9009) for circadian rhythm studies demonstrate that the molecular clock directly regulates metabolic flux via Rev-ErbA occupancy at metabolic gene promoters. Rev-ErbA acts as a critical metabolic sensor that coordinates energy expenditure with the light-dark cycle. When these rhythms are disrupted, cellular metabolism loses its temporal precision, leading to the accumulation of metabolic intermediates and a marked reduction in oxidative capacity. The introduction of SR9009 into these models allows for the pharmacological rescue of circadian-dependent metabolic pathways, providing a tool to investigate the reversal of metabolic syndrome phenotypes in vitro.

Circadian Control of Lipid and Glucose Metabolism

Rev-ErbA modulates the expression of a broad array of genes involved in fatty acid oxidation and lipid transport. Agonism via SR9009 intervention results in the potent suppression of gluconeogenic genes, specifically Pck1 (phosphoenolpyruvate carboxykinase) and G6pc (glucose-6-phosphatase), which effectively reduces hepatic glucose production in synchronized cell cultures. Additionally, the compound influences triglyceride synthesis pathways by regulating the expression of Srebf1 (sterol regulatory element-binding transcription factor 1). This transcriptional control ensures that lipid synthesis is restricted during periods of high metabolic demand, providing a verifiable mechanism for observing changes in lipid profiles within metabolic disruption models.

SR9009 vs. Control: A Comparative Metabolic Analysis

A comparative analysis of treated versus untreated cell models reveals distinct shifts in the bioenergetic profile. Treated models exhibit a significant upregulation of markers associated with oxidative metabolism, which are often suppressed in states of circadian misalignment. Technical documentation typically highlights the following metabolic shifts:

  • Metabolic Markers: Significant increases in CPT1b (carnitine palmitoyltransferase 1b) and UCP3 (uncoupling protein 3) expression indicate an enhanced capacity for fatty acid oxidation.
  • Mitochondrial Density: Treated cell lines show a measurable increase in mitochondrial content. This is a primary downstream effect of Rev-ErbA mediated mitochondrial biogenesis, which enhances the cell’s total energy-producing capacity.
  • Oxygen Consumption Rate (OCR): Real-time metabolic flux analysis confirms elevated OCR in SR9009-treated groups. This serve as a reliable proxy for increased cellular respiration and metabolic activity compared to control groups.

While Rev-ErbA agonism is the primary mechanism discussed, a 2019 study indicated that SR9009 might influence metabolism through pathways independent of the core circadian proteins. This suggests that the compound’s utility in metabolic research is complex, requiring rigorous experimental controls to isolate specific receptor-mediated effects from broader metabolic shifts.

Stenabolic (SR9009) for Circadian Rhythm Studies: A Technical Review of Rev-ErbA Ligands

Laboratory Protocols: Reconstitution, Solubility, and Stability

The technical implementation of Stenabolic (SR9009) for circadian rhythm studies requires precise handling due to the compound’s specific lipophilic properties. Unlike water-soluble peptides, SR9009 is a small molecule that exhibits negligible solubility in aqueous buffers. Achieving a stable, high-concentration stock solution is critical for ensuring that in-vitro assays receive accurate ligand concentrations without introducing excessive solvent toxicity. Replicable results in chronobiological research depend entirely on the initial preparation and the subsequent preservation of the ligand’s molecular integrity.

Optimizing Solubility for In-Vitro Delivery

Maximum solubility for SR9009 is typically achieved using Dimethyl Sulfoxide (DMSO) or Ethanol. Technical data indicates that SR9009 reaches a saturation point in DMSO at approximately 25 mg/mL. In contrast, solubility in anhydrous Ethanol is significantly lower, peaking at roughly 5 mg/mL. To facilitate complete dissolution, sonication is often employed for 10 to 15 minutes at room temperature. Heating the solvent above 37°C is generally discouraged, as it may accelerate oxidative degradation. Once the stock solution is prepared, it must be diluted into the culture medium to a final concentration that maintains solvent levels below 0.1% v/v to prevent interference with cellular circadian oscillations. A methodical dilution series is the standard approach for minimizing solvent-induced stress in sensitive cell lines.

Storage and Quality Assurance Standards

The stability of SR9009 varies significantly based on its physical state and environmental exposure. In its lyophilized form, the compound remains stable for up to 24 months when stored at -20°C in a desiccated environment. Once reconstituted in DMSO, the shelf-life is drastically reduced; liquid aliquots should be used within 4 weeks and maintained at -80°C to minimize degradation. Repeated freeze-thaw cycles must be avoided, as they compromise the binding affinity of the ligand to the Rev-ErbA receptor.

Verifying experimental reproducibility requires the use of certified peptides and chemicals that are accompanied by comprehensive analytical documentation. Researchers should prioritize batches that include third-party HPLC (High-Performance Liquid Chromatography) and MS (Mass Spectrometry) reports. These metrics confirm the purity level, typically requiring a minimum threshold of 98%, and ensure the absence of residual synthesis catalysts. For laboratories requiring analytical consistency, it is essential to source high-purity Rev-ErbA ligands from suppliers that provide verifiable batch-specific data. This rigorous approach to sourcing and storage provides the foundation for high-stakes precision in metabolic and chronobiological research.

Sourcing Stenabolic (SR9009) for Professional Research in Europe

High-stakes precision in molecular biology demands verifiable chemical metrics. When implementing Stenabolic (SR9009) for circadian rhythm studies, the integrity of the resulting data is inextricably linked to the purity of the Rev-ErbA ligand. Inconsistent chemical grades introduce significant risk, as impurities can trigger off-target effects that confound observations of gene transcription and metabolic flux. For researchers operating within the European Union, sourcing from regional suppliers provides essential logistical reliability. Localized supply chains minimize the duration of transit, reducing the potential for compound degradation due to temperature fluctuations or improper handling. This regional focus ensures that the ligand arrives with its molecular stability intact, ready for immediate reconstitution in a controlled laboratory setting.

EuroLab Peptides addresses these rigorous demands through a multi-level quality control process. Every batch of SR9009 undergoes exhaustive analytical validation to ensure it meets the stringent requirements of professional research. It’s important to understand that all procurement of Rev-ErbA agonists is governed by a strict research-only mandate. These chemicals are synthesized exclusively for in-vitro laboratory use and developmental research. They aren’t intended for human consumption or clinical applications, a distinction that EuroLab Peptides maintains with absolute transparency to uphold the ethical and legal standards of the scientific community.

The Critical Nature of Third-Party Testing

In-house testing, while useful for preliminary screening, is often insufficient for the high-stakes requirements of peer-reviewed publication preparation. Independent third-party laboratory testing provides an objective layer of validation that instills a sense of absolute security in the experimental design. This external scrutiny utilizes HPLC and Mass Spectrometry to confirm the absence of synthesis byproducts, heavy metals, or residual solvents. By relying on independent metrics, laboratories can ensure that the biological responses observed are a direct result of Rev-ErbA activation. This level of analytical consistency is a non-negotiable standard for replicable research, allowing scientists to focus on data interpretation rather than questioning the purity of their reagents.

Procurement and Compliance for European Laboratories

Streamlined logistics are vital for research institutions across Europe, especially when conducting multi-phase studies that require a consistent supply of standardized chemicals. EuroLab Peptides provides a reliable supply chain that facilitates the acquisition of high-purity ligands without the delays often associated with international customs. This efficiency allows for the seamless execution of long-term protocols. Whether your work involves the Advanced Metabolic Stack or individual Rev-ErbA ligands, maintaining a relationship with a meticulous partner ensures that every assay is supported by empirical results. As a final reminder, these products are strictly for laboratory development, ensuring that your facility remains in full compliance with regional regulatory standards.

Advancing Chronobiological Research with Precision Ligands

Precision in Rev-ErbA agonism is the primary requirement for mapping circadian-dependent metabolic flux. The utilization of Stenabolic (SR9009) for circadian rhythm studies provides a unique mechanism to probe the intersection of temporal gene regulation and systemic metabolism. Success in these complex laboratory models hinges on the meticulous application of solubility protocols and the preservation of compound stability throughout the experimental duration. By isolating the effects of Rev-ErbA activation, researchers can resolve the intricacies of peripheral clock synchronization with high-stakes precision.

EuroLab Peptides ensures analytical consistency through a multi-level quality control process. Every batch is third-party laboratory tested to confirm a purity benchmark of >99%, specifically dedicated to in-vitro research standards. Rapid European-wide shipping facilitates a reliable supply chain for multi-phase designs, ensuring that your research remains focused on data interpretation rather than chemical variability. Reliable results are built on a foundation of verifiable chemical integrity. Access high-purity SR9009 for your research at EuroLab Peptides and advance your chronobiological inquiries with absolute confidence.

Frequently Asked Questions

What is the primary mechanism of action for Stenabolic (SR9009)?

SR9009 functions as a synthetic agonist for the nuclear receptors Rev-ErbA alpha and Rev-ErbA beta. By binding to these receptors, it increases their repressive activity within the cell. This interaction recruits the NCoR-HDAC3 corepressor complex to the promoter regions of target genes. The primary result is the suppression of genes involved in metabolic pathways and circadian regulation, providing a measurable dial for researchers investigating temporal cellular processes.

Is SR9009 classified as a SARM in research literature?

Scientific literature does not classify SR9009 as a Selective Androgen Receptor Modulator (SARM). While it’s frequently mislabeled in non-professional contexts, it lacks affinity for the androgen receptor. It’s correctly defined as a synthetic ligand for Rev-Erb receptors. This distinction is vital for experimental design, as SR9009 doesn’t induce the hormonal or androgenic effects associated with SARMs, focusing instead on the direct modulation of the molecular clock.

What solvents are most effective for SR9009 reconstitution in a lab?

Dimethyl Sulfoxide (DMSO) and Ethanol are the most effective solvents for achieving stable reconstitution. SR9009 exhibits a solubility of approximately 25 mg/mL in DMSO, which is the preferred medium for high-concentration stock solutions. In anhydrous Ethanol, solubility is significantly lower, typically reaching 5 mg/mL. Aqueous buffers are ineffective due to the compound’s lipophilic nature. Researchers must ensure that final solvent concentrations in culture media remain below 0.1% to avoid cytotoxicity.

How does SR9009 influence the BMAL1/CLOCK gene expression?

The application of Stenabolic (SR9009) for circadian rhythm studies results in the direct repression of BMAL1 gene transcription. Rev-Erb receptors compete with RORs for binding at the RORE promoter site. When SR9009 activates Rev-Erb, it shifts the balance toward transcriptional inhibition. This suppression disrupts the core negative feedback loop, allowing for the precise manipulation of circadian amplitude and phase within synchronized in-vitro models without the interference of systemic variables.

Can SR9009 be used for in-vivo clinical trials?

SR9009 is strictly limited to in-vitro research and laboratory development purposes. It’s not intended for human consumption or clinical use in vivo. As of 2026, there are no approved human clinical trials for this compound. All procurement through professional channels must adhere to this mandate. Utilizing research chemicals outside of a controlled laboratory environment violates safety protocols and regulatory standards established for the specialized scientific community.

What is the recommended storage temperature for lyophilized SR9009?

Lyophilized SR9009 should be stored at -20°C in a desiccated environment to ensure long-term stability. Under these conditions, the compound maintains its chemical integrity for up to 24 months. Once reconstituted in a solvent like DMSO, the storage requirement shifts to -80°C to minimize degradation. Aliquoting the solution is a standard practice to prevent repeated freeze-thaw cycles, which can compromise the ligand’s binding affinity and the overall reproducibility of the assay.

How does Rev-ErbA agonism affect mitochondrial biogenesis?

Rev-ErbA agonism serves as a potent driver of mitochondrial biogenesis in various cell lines. Activation of Rev-Erb receptors by ligands like SR9009 leads to the upregulation of genes involved in mitochondrial respiration and fatty acid oxidation. This process increases both the density and functional capacity of mitochondria within the cell. Researchers utilize this mechanism to investigate the metabolic shifts associated with circadian synchronization and energy homeostasis in skeletal muscle and hepatic models.

Why is third-party testing essential for SR9009 research?

Independent third-party testing is essential to verify a purity benchmark of >99%, ensuring that data is not skewed by contaminants. Professional suppliers like EuroLab Peptides utilize HPLC and Mass Spectrometry to provide empirical proof of chemical consistency. Without this external validation, researchers risk off-target effects that compromise peer-reviewed publication integrity. High-purity ligands are a non-negotiable requirement for establishing replicable protocols in complex Stenabolic (SR9009) for circadian rhythm studies.

Scroll to Top

Eurolab Peptides

EuroLab Peptides provides materials strictly for scientific laboratory research. To continue, you must acknowledge the following:

Age Requirement
  • All customers must be at least 18 years of age
  • Customers located in the United States must be 21 years of age or older
Product Use
  • All products are sold for in-vitro research purposes only
  • Not intended for human or animal consumption
  • Not for cosmetic use or use as dietary supplements
No Medical Advice
  • EuroLab Peptides is not a pharmacy or medical provider
  • We do not provide medical advice, diagnostic services, dosing instructions, or guidance for human use
Compliance & Responsibility
  • Purchasers are solely responsible for ensuring proper handling of materials
  • All materials must be used in accordance with institutional safety protocols
  • Compliance with all applicable local, national, and international laws and regulations is required
Sales Policy
  • Due to the specialized nature of research materials, all sales are final
  • Returns or exchanges are not accepted
  • Please review our Shipping & Returns Policy for information on damaged shipments or delivery issues

By clicking “I Agree”, you confirm that you have read, understood, and agreed to our Terms & Conditions, Disclaimer, and Shipping & Returns Policy.